Marina Kleanthous

2.6k total citations
80 papers, 1.3k citations indexed

About

Marina Kleanthous is a scholar working on Genetics, Hematology and Genetics. According to data from OpenAlex, Marina Kleanthous has authored 80 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Genetics, 31 papers in Hematology and 25 papers in Genetics. Recurrent topics in Marina Kleanthous's work include Hemoglobinopathies and Related Disorders (53 papers), Iron Metabolism and Disorders (25 papers) and Prenatal Screening and Diagnostics (17 papers). Marina Kleanthous is often cited by papers focused on Hemoglobinopathies and Related Disorders (53 papers), Iron Metabolism and Disorders (25 papers) and Prenatal Screening and Diagnostics (17 papers). Marina Kleanthous collaborates with scholars based in Cyprus, United Kingdom and Greece. Marina Kleanthous's co-authors include Carsten W. Lederer, Pavlos Fanis, Marios Phylactides, Petros Kountouris, John Old, Mutay Aslan, Kyriacos Kyriacou, Eleni Ι. Kalogirou, Joanne Traeger‐Synodinos and P.A. Ioannou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Marina Kleanthous

77 papers receiving 1.3k citations

Peers

Marina Kleanthous
DR Higgs United Kingdom
Shi‐Ping Cai United States
Y. Terry Lee United States
Stephan Lobitz Germany
Panayiota Trifillis United States
Dijana Plaseska‐Karanfilska North Macedonia
Mei‐Chi Cheung United States
Marie Eve Moreau Canada
Cathy Meaney United Kingdom
Fatima Dhalla United Kingdom
DR Higgs United Kingdom
Marina Kleanthous
Citations per year, relative to Marina Kleanthous Marina Kleanthous (= 1×) peers DR Higgs

Countries citing papers authored by Marina Kleanthous

Since Specialization
Citations

This map shows the geographic impact of Marina Kleanthous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Kleanthous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Kleanthous more than expected).

Fields of papers citing papers by Marina Kleanthous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Kleanthous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Kleanthous. The network helps show where Marina Kleanthous may publish in the future.

Co-authorship network of co-authors of Marina Kleanthous

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Kleanthous. A scholar is included among the top collaborators of Marina Kleanthous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Kleanthous. Marina Kleanthous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomazou, Marios, et al.. (2024). Context base editing for splice correction of IVSI-110 β-thalassemia. Molecular Therapy — Nucleic Acids. 35(2). 102183–102183. 5 indexed citations
2.
Stephanou, Coralea, et al.. (2023). IthaPhen: An Interactive Database of Genotype-Phenotype Data for Hemoglobinopathies. HemaSphere. 7(7). e922–e922. 2 indexed citations
3.
Lederer, Carsten W., Tina Buerki‐Thurnherr, Stefania La Grutta, et al.. (2022). Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies. Pharmaceutics. 14(4). 793–793. 7 indexed citations
4.
Tamana, Stella, Coralea Stephanou, Cornelis L. Harteveld, et al.. (2022). Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies. eLife. 11. 5 indexed citations
5.
Parpottas, Y., et al.. (2019). 57Fe enrichment in mice for β-thalassaemia studies via Mössbauer spectroscopy of blood samples. European Biophysics Journal. 48(7). 635–643. 5 indexed citations
6.
Kleanthous, Marina, et al.. (2019). Disruptive Technology: CRISPR/Cas-Based Tools and Approaches. Molecular Diagnosis & Therapy. 23(2). 187–200. 20 indexed citations
7.
Kleanthous, Marina, et al.. (2019). Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases. Molecular Diagnosis & Therapy. 23(2). 201–222. 42 indexed citations
8.
9.
Stephanou, Coralea, et al.. (2017). Suitability of small diagnostic peripheral-blood samples for cell-therapy studies. Cytotherapy. 19(2). 311–326. 6 indexed citations
10.
Finotti, Alessia, Laura Breda, Nicoletta Bianchi, et al.. (2015). Recent trends in the gene therapy of β-thalassemia. SHILAP Revista de lepidopterología. 17 indexed citations
11.
Aslan, Mutay, et al.. (2015). Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biology. 6. 226–239. 121 indexed citations
12.
Georgiou, Theodoros, George Christopoulos, Violetta Anastasiadou, et al.. (2014). The first family with Tay-Sachs disease in Cyprus: Genetic analysis reveals a nonsense (c.78G>A) and a silent (c.1305C>T) mutation and allows preimplantation genetic diagnosis. Meta Gene. 2. 200–205. 6 indexed citations
13.
Phylactides, Marios, et al.. (2009). Compounds of the anthracycline family of antibiotics elevate human γ-globin expression both in erythroid cultures and in a transgenic mouse model. Blood Cells Molecules and Diseases. 44(2). 100–106. 5 indexed citations
14.
Harteveld, Cornelis L., Marina Kleanthous, & Joanne Traeger‐Synodinos. (2009). Prenatal diagnosis of hemoglobin disorders: Present and future strategies. Clinical Biochemistry. 42(18). 1767–1779. 21 indexed citations
15.
Kleanthous, Marina, et al.. (2008). Arrayed Primer Extension for the Noninvasive Prenatal Diagnosis of β‐Thalassemia Based on Detection of Single Nucleotide Polymorphisms. Annals of the New York Academy of Sciences. 1137(1). 302–308. 46 indexed citations
16.
Akbari, Mohammad Taghi, et al.. (2008). Molecular Basis of Thalassemia Intermedia in Iran. Hemoglobin. 32(5). 462–470. 17 indexed citations
17.
18.
Christopoulos, George, et al.. (2001). Hb LIMASSOL [β8(A5)Lys → Asn]: A NEW HEMOGLOBIN VARIANT. Hemoglobin. 25(4). 421–424. 5 indexed citations
19.
Kleanthous, Marina, et al.. (2001). Alpha‐thalassaemia prenatal diagnosis by two PCR‐based methods. Prenatal Diagnosis. 21(5). 413–417. 7 indexed citations
20.
Marwan, Mohamed, Christian Scerri, Antonio Cao, et al.. (1999). ComparativeIn VivoExpression of β+-Thalassemia Alleles. Hemoglobin. 23(3). 221–229. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DR Higgs Breakdown of academic impact, for papers by Shi‐Ping Cai Breakdown of academic impact, for papers by Y. Terry Lee Breakdown of academic impact, for papers by Stephan Lobitz Breakdown of academic impact, for papers by Panayiota Trifillis Breakdown of academic impact, for papers by Dijana Plaseska‐Karanfilska Breakdown of academic impact, for papers by Mei‐Chi Cheung Breakdown of academic impact, for papers by Marie Eve Moreau Breakdown of academic impact, for papers by Cathy Meaney Breakdown of academic impact, for papers by Fatima Dhalla
Rankless by CCL
2026